Qingqiang Ni

3PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 03, 2026
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

|May 16, 2024
Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.

Qingqiang Ni, Hongtao Jia, Yazhou Zhang

|Feb 21, 2024
Puerarin protects the fatty liver from ischemia-reperfusion injury by regulating the PI3K/AKT signaling pathway.

Faji Yang, Hengjun Gao, Zheyu Niu

Pageof 1

Frequent Collaborators

1 joint publications

Gang Chen

1 joint publications

Yong-Yi Zeng

1 joint publications

Jian-Hua Rao

1 joint publications

Lin-Sen Ye